Our previous studies have demonstrated that MRPL12 is implicated in various metabolic diseases, including diabetic nephropathy, acute kidney injury, liver cancer, and lung cancer, through its regulation of mitochondrial biosynthesis [18–24]. Here, MRPL12 is linked to metabolic disease.